Articles & Other Writings 
Urology Practice, co-author, retrospective chart review analysis of genomic assay used in men newly diagnosed with prostate cancer (November 2015; online July 2015) Abstract
—​ European Respiratory Journal, Clarity Pharma study, prevalence of a rare lung infection in Europe, co-written with international team of medical experts (September 2014) Abstract
European Respiratory Journal, Clarity Pharma study, treatment patterns for a rare lung infection in Europe, US and Japan, co-written with international team of medical experts (September 2014) Abstract
Annals of the American Thoracic Society, US study of rare lung infection, co-written with 2 NIH epidemiologists and a professor of medicine on national ATS guidelines committee (January 2014) Abstract
World Journal of Urology, 5-nation European cancer study, co-written with 2 European urology oncologists on disease treatment guidelines panel (April 2014)
The Journal of Urology, cancer study, co-writtten with nationally known medical researchers (May 2012 – offered for Category 1 CME credit)
The Journal of Urology, cancer practice patterns,
AUA Annual Meeting Program Abstracts special issue,

(April 2011) Citation
Journal of Dermatological Treatment, article on actinic keratoses treatments and outcomes (2006)
Journal of Health Care Marketing, article on a study of patient selection of orthopedists, podiatrists and PCPs for foot treatments, by Clarity chief scientist, reprinted in the book Health Care Marketing: A Foundation for Managed Quality (3rd ed., Philip D. Cooper, editor) 
Abstract; Chapter
Journal of Health Care Marketing, Violating assumptions of statistical procedures: JHCM reporting guidelines (September 1990)
Journal of Health Care Marketing, Invalid Patient Surveys: Not a Bargain at Any Price (March 1989)
Nursing Management, article on developing an optimal nurse staffing system (March 1987)
American Journal of Mental Deficiency, article on Dr. Gallagher's experimental study of short-term memory in the cognitively impaired.
— Changing Behavior: How and Why (book by Dr. Gallagher, Silver Burdett Professional Publications)

A Sampling of Our Published Research & Presentations

Clarity and co-investigators have presented at a number of conferences in the US and Europe.We presented this poster at the 2012 PMRG Institute (view PDF).

(Including nonproprietary findings for study physician participants and the public, with clients’ permission) 

(Click on links in gray to view or download materials)


Disadvantages of Commonly Used Alternatives to a Patient Records Approach (PDF)
Sargramostim (GM-CSF) as Immunotherapy (PDF)
CSF Efficacy and Other Key Attributes (PDF)
National Representative Actinic Keratoses Study: Key Findings Among Dermatologists (PDF)
National Representative Actinic Keratoses Study: Key Findings Among PCPs (PDF)
National Descriptive Blood and Marrow Study: Transplants Performed in US (PDF)
HIV / AIDS Anemia (PDF)
Hepatitis C Treatment Associated Anemia (PDF)
Metastatic Melanoma Treatment (PDF)
Basal Cell Carcinoma Treatment (PDF)
Metastatic Renal Cell Carcinoma Treatment (PDF)
Undiagnosed Chronic Kidney Disease Among Rheumatoid Arthritis Patients (PDF)
How Patient-Records Methodology Can Help Overcome Shortcomings of ATU and Syndicated Data (PDF)
Why Peer-Reviewed Publications Matter to Your Business (PDF)

White Papers

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress, retrospective observational study to capture economic burden evidence in a rare disease (November 2015, Milan, Italy) AbstractPoster

— EphMRA (European Pharmaceutical Market Research Association), “Precedent and consequence research to undergird orphan reimbursement strategy – A multi-layered, non-traditional approach,” (June 2015, Amsterdam, Netherlands) Presentation

Japanese Respiratory Society, Co-author, poster presentation on Clarity Pharma study comparing treatment patterns for a rare lung disease in EU5, Japan and US (April 2015, Tokyo, Japan) Abstract

 European Respiratory Society, Co-author of presentation on Clarity study of prevalence and incidence of a rare lung disease in Europe: Text and Poster1; co-author, comparisons of treatment patterns for the disease in EU5, Japan and US (September 2014, Munich, Germany) Text; Poster2

— KIT 2014 (Congress for Infectious Diseases and Tropical Medicine), co-author, rare lung infection prevalence in Germany (June 2014, Cologne) Abstract

— EphMRA Annual conference, fieldwork challenges debate, (June 2013, London) Presentation
American Thoracic Society (ATS) International Conference, study of rare lung infection, co-written with 2 NIH epidemiologists (May 2013, Philadelphia) Abstract
PMRG Institute (Pharmaceutical Marketing Research Group), cancer study and sample validity (October 2012, Philadelphia) Abstract; Poster
PBIRG (Pharmaceutical Business Intelligence and Research Group), presentation on sample validity (May 2012, Chicago) Poster
Market Research Society (MRS) Healthcare Research Conference, surveys (February 2012, London) Presentation
Society of Urologic Oncology (SUO) Annual Meeting in conjunction with World Urologic Oncology Federation, cancer study (December 2011, Rockville, Md.) Poster
American Urological Association (AUA) Annual Meeting, cancer study (May 2011, Washington, D.C. – one of 696 selected from 6,638 submissions) Abstract; Presentation
ISPOR 16th Annual International Meeting, posters based on Clarity cancer study (May 2011, Baltimore, Md.) Presentation1; Presentation2
ASCO, Duration of Therapy of Colony Stimulating Factors (May 2002) Paper

  • Our research has withstood the scrutiny of peer-review journals and medical conferences, which can help you in showing evidence of value and efficacy to payors and regulators. 

  • Clarity's co-investigators have contributed to medical research and have served at prestigious agencies, medical schools, and universities in the US and overseas.

© 2014-2017 Clarity Pharma Research LLC  |  All Rights Reserved Privacy Policy
To learn more about our services, call (864) 208-0078 or contact
Subscribe to our newsletter at: